SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Furosemide for Injection in the ...
Hikma has launched furosemide injection, in 20mg/2ml, 40mg/4ml, 100mg/10ml, 500mg/50ml and 1,000mg/100ml presentations. “Hikma is introducing the first FDA approved 50ml and 100ml presentations to the ...
SQ Innovation's Lasix(R) ONYU Now Available for Order Through Major U.S. Pharmaceutical Distributors
The MarketWatch News Department was not involved in the creation of this content. Addressing a Leading Cause of Hospitalization in Older Adults with Heart Failure BURLINGTON, Mass., Feb. 9, 2026 ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...
BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (LGND) today announced that its partner SQ Innovation Inc. has received approval from the U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . scPharmaceuticals Inc. announced the FDA approved its self-administered subcutaneous furosemide injection for ...
The U.S. Food and Drug Administration has approved Lasix ONYU, an at-home version of the common heart failure drug Lasix The device allows safe treatment for fluid buildup without hospital IV infusion ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results